People
-
Retrophin, which is developing Syntocinon intranasal oxytocin, has named Stephen Aselage as President and Chief Operations Officer and Alvin Shih as Executive VP of Research and Development. Aselage, who has stepped down as CEO, was… Read more . . .
-
Arikayce inhaled liposomal amikacin developer Insmed has announced that former AstraZeneca CEO David R. Brennan will join the company’s board of directors. Insmed Chairman of the Board Donald J. Hayden commented, “We are delighted to… Read more . . .
-
Discovery Laboratories has hired former AstraZeneca Senior Medical Director Steve Simonson as VP, Clinical Development and former PARI VP and Director of Product Technology Lawrence Weinstein as VP, Medical Device Development, the company said. The… Read more . . .
-
The organizers of RDD 2014 have announced that the 2014 winner of the Charles G. Thiel Award is Dieter Hochrainer of Boehringer Ingelheim. The award was presented by Peter Byron at the opening of the… Read more . . .
-
Alexza Pharmaceuticals has hired Winston R. Brown, Jr. as VP, Quality, the company has announced. Brown was most recently Global Head, Quality R&D – Pharmaceuticals, Biologics, and Vision Care Devices at Alcon Research. The company… Read more . . .
-
CDMO Molecular Profiles says that it has hired Charles D. Maher as head of US sales in order to “increase awareness and uptake of its pharmaceutical development services in the North American market.” The company’s… Read more . . .
-
In anticipation of the potential commercialization of its Arikayce inhaled liposomal amikacin, Insmed has announced a number of management changes designed to “better align the organization with the company’s growth opportunities.” Those changes are: Renu… Read more . . .
-
The FDA has announced a funding opportunity for a research project titled “Development of Clinically Relevant In Vitro Performance Test for Generic OIDPs: Physiologically Relevant Models for Aerodynamic Particle Size Distribution Analysis.” Two grants of… Read more . . .
-
3M Drug Delivery Systems has announced that Cindy R. Kent has succeeded James Ingebrand as President and General Manager, effective February 2014. Ingebrand will now head 3M’s dental division. Kent joined 3M in October 2013… Read more . . .
-
CDMO Formex, formerly PharmaForm, has hired Steve Massah as President and CEO. Massah joins Formex from Gilead, where he worked in Strategic Drug Product Manufacturing and Outsourcing. He has previously held management positions with Avanir,… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA